Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

60% of practices not moving to accountable care

The majority of physician practices have not joined an accountable care organization and don't plan to, according to a study published online in the journal Health Services Research.

Barriers hinder mobile health but rapid growth still expected

Mobile health holds promise for the future of healthcare delivery but lack of reimbursement and uncertainty about regulation and standards are hindering innovation in the industry, according to a new report from the Brookings Institute's Center for Technology Innovation.

Thumbnail

Majority of physician practices not joining ACOs

A national telephone survey finds that 60.6 percent of physician organizations report no current involvement and no plans to become involved in an accountable care organization (ACO) in the near future.

Thumbnail

ASPR launches health IT-EMS campaign

The Department of Health & Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) has launched a collaboration community campaign on IdeaScale that will facilitate the exchange of ideas regarding health IT use in public health and medical emergency preparedness, response and recovery.

Thumbnail

Health IT’s Role In Hospital Consolidation

Market monopoly or better for patients? The debates rages on but health IT is an important factor. 

Thumbnail

Preparing For the New Frontier of Healthcare Consumerization

The ever-growing focus on patient engagement means healthcare delivery organizations need to make themselves attractive to patient consumers. Providers must prepare for a consumer-centric healthcare system.

Thumbnail

HHS Inspector General Advocates for Random Drug Tests in All Health Care Workers, Including M.D.s

Everyone involved in health care that has access to controlled substances, whether they be a doctor or medical staff, should be subject to random drug tests opines Daniel R. Levinson, the inspector general for the U.S. Department of Health and Human Services (HHS) and Erika T. Broadhurst, the OIG special agent on a 2013 case involving a fentanyl addicted technologist who infected more than 40 people with Hepatitis C by replacing fentanyl needles he stole with his own dirty needles filled with saline.

Workflow improvements for enhanced EHR functionality

Utilizing human factor workflow modeling tools, process mapping and goals-means decomposition, a recent report by the National Institute of Standards and Technology unearthed a number of insights on end-user needs to improve EHR workflow for clinicians in outpatient care settings.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.